17 Capital Partners’s Medtronic MDT Stock Holding History

17 Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$753K	Sell	9,626 -224	-2%	-$18.1K	0.34%	99
2026 Q1	$854K	Buy	9,850 +565	+6%	+$54.1K	0.44%	81
2025 Q4	$892K	Sell	9,285 -9	-0.1%	-$874	0.46%	75
2025 Q3	$885K	Hold	9,294	–	–	0.48%	76
2025 Q2	$810K	Sell	9,294 -1,172	-11%	-$99.4K	0.47%	75
2025 Q1	$940K	Sell	10,466 -100	-0.9%	-$8.95K	0.6%	56
2024 Q4	$844K	Sell	10,566 -329	-3%	-$28.5K	0.53%	70
2024 Q3	$981K	Hold	10,895	–	–	0.64%	59
2024 Q2	$858K	Sell	10,895 -333	-3%	-$27.3K	0.61%	60
2024 Q1	$979K	Hold	11,228	–	–	0.72%	48
2023 Q4	$925K	Buy	+11,228	New	+$856K	0.85%	44
2022 Q3	$886K	Sell	10,978 -226	-2%	-$20.3K	1.21%	41
2022 Q2	$1.01M	Sell	11,204 -103	-0.9%	-$10.4K	1.27%	35
2022 Q1	$1.25M	Hold	11,307	–	–	1.31%	32
2021 Q4	$1.17M	Sell	11,307 -614	-5%	-$71.1K	1.07%	38
2021 Q3	$1.49M	Buy	11,921 +42	+0.4%	+$5.44K	1.41%	19
2021 Q2	$1.48M	Buy	+11,879	New	+$1.49M	1.37%	21

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

17 Capital Partners's MDT Position: Q2 2026 in Review

17 Capital Partners reduced its Medtronic (MDT) stake by 2.3% in Q2 2026, selling an estimated $18.1K and leaving 9,626 shares worth $753K. The position accounts for 0.34% of the portfolio, ranked #99.

17 Capital Partners first reported a position in MDT in Q2 2021 and has held it in 17 quarters since. The position peaked at $1.49M in Q3 2021. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

17 Capital Partners held 9,626 shares of Medtronic worth $753K as of Q2 2026.
17 Capital Partners sold 224 Medtronic shares in Q2 2026, an estimated $18.1K.
Medtronic made up 0.34% of 17 Capital Partners's portfolio in Q2 2026, its #99 holding.
17 Capital Partners first reported a position in Medtronic in Q2 2021 and has held it in 17 quarters since.
17 Capital Partners's Medtronic position peaked at $1.49M in Q3 2021.
2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on 17 Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.